Gendius

About:

Gendius is a diabetes management platform helping its consumers check and level diabetes.

Website: http://www.gendius.co.uk

Twitter/X: intellin_

Top Investors: Innovate UK, GM&C Life Sciences Fund, Momentum Fund

Description:

Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focusses the individual on clinically validated tasks and measures to slow their progression in these areas.

Total Funding Amount:

$996000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Chester, Cheshire, United Kingdom

Founded Date:

2011-01-01

Contact Email:

roryc(AT)gendius.co.uk

Founders:

Chris Genders, Rory Cameron

Number of Employees:

11-50

Last Funding Date:

2020-07-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai